Business Context and Reporting Period
Company: Revelation Biosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 10, 2025
Reporting Period: Event date February 10, 2025
The filing reports the public release of an updated corporate presentation. The company is incorporated in Delaware and trades on The Nasdaq Stock Market LLC under the symbols REVB (Common Stock) and REVBW (Redeemable Warrants).
Key Financial Metrics
This Form 8-K does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing serves solely to announce the availability of a corporate presentation.
Material Changes
No material financial changes or operational updates are detailed within the text of this filing. The only reported event is the dissemination of the corporate presentation attached as Exhibit 99.1.
Guidance, Outlook, and Risks
Management Commentary: The Company made an updated corporate presentation available on its website and attached it as Exhibit 99.1.
Legal Disclaimer: The information contained in Item 8.01 and Exhibit 99.1 is not treated as "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It will not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review the attached Corporate Presentation (Exhibit 99.1) for specific operational updates, pipeline data, or financial guidance not included in this summary.
- Verify the current trading status and price of REVB and REVBW on The Nasdaq Stock Market.
- Confirm the date of the presentation (February 10, 2025) to ensure data currency.
- Note that the presentation content is not legally "filed" with the SEC for liability purposes under Section 18.